Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash flows from operating activities:
Net (loss)	$ (305,510)	$ (671,999)
Adjustments to reconcile net loss to net cash (used in) operating activities
Depreciation		759
Common stock issued for services rendered	207,035	473,430
Other Assets	(7,000)
Accounts payable and accrued expenses	9,100	(40,898)
Due from related party	(12,296)
Deferred revenue
Net cash (used in) operating activities:	(101,671)	(238,708)
Cash flows from investing activities
Increase in patent cost	(7,000)
Net cash (used in) investing activities:	(7,000)
Cash flows from financing activities
Proceeds from issuance of common stock	250,000
Proceeds from exercise of warrants		27,346
Repayment of officer loan payable		(2,400)
Net cash provided by financing activities	250,000	(24,946)
Net increase/(decrease) in cash	141,329	(213,762)
Cash and cash equivalents beginning of period	152,526	400,848
Cash and cash equivalents end of period	293,855	187,086
Common stock issued for payable		17,375
Interest
Income taxes